AI threat detection in healthcare exposes the output gap

At a glance

What this is: This analysis argues that healthcare AI security is failing at the output layer, where agent behavior can leak PHI or poison clinical recommendations without triggering traditional detection.

Why it matters: It matters to IAM practitioners because AI agents, service accounts, and workflow-integrated identities now create access and write-back paths that must be governed as part of identity, privilege, and runtime control design.

By the numbers:

• The first AI-orchestrated cyber espionage campaign was detected in November 2025, and 80% to 90% of the operations were AI-executed.
• When AWS credentials are exposed publicly, attackers attempt access within an average of 17 minutes and as quickly as 9 minutes in some cases.

👉 Read ARMO's analysis of AI threat detection gaps in healthcare

Context

Healthcare AI detection is breaking at the point where an agent writes back into an EHR, orders workflow, or clinical knowledge store. The primary gap is not whether the model is observable, but whether existing security stacks can tell the difference between authorised activity and manipulated output in an AI-mediated workflow.

That distinction matters because AI agents increasingly behave like non-human identities with persistent permissions, delegated tool access, and approved destinations. When those identities are allowed to read, reason, and write inside clinical systems, the governance problem shifts from perimeter inspection to runtime control of what the agent is allowed to produce.

ARMO’s analysis shows that this is not a niche detection challenge. It is a structural blind spot that affects healthcare organisations already relying on DLP, EHR audit logs, CNAPP, EDR, and SIEM as if those controls were sufficient for AI-mediated data movement and decision support.

Key questions

Q: What breaks when AI agents can write into clinical systems without output governance?

A: The control failure is that security teams end up governing access paths while missing the behaviour that matters most: what the agent writes back. When output can change silently inside an approved workflow, DLP, EHR audit logs, and egress tools may all stay green while clinical decisions are corrupted. That is a governance failure in the agent identity and write authority, not just a monitoring gap.

Q: Why do AI agents complicate zero trust and least privilege?

A: AI agents complicate zero trust because valid authentication does not guarantee contextually safe behaviour. They can hold legitimate credentials while still performing actions that the initiating user should not be allowed to do directly. Least privilege also becomes harder because access can expand through integrations and shared workflows unless it is continuously constrained.

Q: How can organisations tell whether AI output drift is a security problem or a model-quality issue?

A: The key signal is correlation. If the output shift aligns with a logged model update, policy change, or retrieval corpus change, it may be legitimate. If the shift appears without a matching deployment event and repeats across cases, treat it as a security incident and investigate the upstream context, permissions, and data sources.

Q: What should teams do when a clinical AI agent shows suspicious recommendation drift?

A: They should freeze the affected workflow, preserve the agent’s runtime and retrieval evidence, and review recent changes to prompts, data sources, and write permissions before restoring service. The goal is to stop further contaminated decisions and determine whether the drift came from poisoned content, delegated access abuse, or a compromised upstream source.

Technical breakdown

Why destination-layer controls miss AI-mediated PHI exfiltration

Traditional destination-layer controls assume that exfiltration is visible as data leaving a trusted boundary. In healthcare AI workflows, that assumption fails when a managed model endpoint, embedding service, or internal vector store is already allowlisted. The agent can move PHI through approved channels, and the control stack sees only authorised destinations, not the semantic meaning or intent of the content. This is where non-human identity governance intersects with AI operations: the agent’s credentials and tool permissions define the path, but the risk emerges from the behaviour at runtime.

Practical implication: teams need per-agent behavioural baselines, not just destination allowlists.

How write-path baselining detects contaminated clinical output

Contaminated clinical output is harder to catch because it may never produce an egress event. The agent’s output is written into the EHR or clinical workflow as if it were legitimate work, which means DLP, network monitoring, and container runtime tools can all remain silent. Detection has to move up one layer and examine whether the agent’s write-back behaviour, recommendation distribution, or tool-call sequence has drifted from its expected case-class baseline. In practice, this is a runtime integrity problem for the agent’s identity and permissions, not just a content inspection problem.

Practical implication: establish write-path content baselines for each AI agent class and case type.

Why cross-signal correlation is now part of security architecture

No single log source is enough to explain AI-mediated contamination. A security team needs to correlate the upstream trigger, the agent’s retrieval behaviour, and the downstream write event into one narrative. That is why application-layer correlation matters: it fuses deployment state, retrieval corpus changes, and runtime output shifts into a single investigation surface. For AI agents operating inside healthcare systems, the architectural issue is not log volume. It is the absence of a machine-readable chain of causality that can survive clinical response times.

Practical implication: build correlation between retrieval changes, agent output drift, and EHR write events.

Threat narrative

Attacker objective: The attacker wants to manipulate clinical decisions or move patient data through trusted AI workflows without triggering existing destination-layer detection.

1. Entry occurs when a healthcare agent retrieves poisoned guidance or is induced to use compromised context inside the clinical workflow.
2. Escalation happens when the agent’s permitted tool access and write-back permissions convert that poisoned context into biased recommendations or approved data movement.
3. Impact appears as PHI exposure through allowlisted destinations or contaminated clinical output inside the EHR, with downstream decisions made on corrupted information.

NHI Mgmt Group analysis

AI detection in healthcare is now an identity governance problem, not just a monitoring problem. When an AI agent can read, reason, and write inside clinical systems, the relevant control question becomes who or what is authorised to act, under which conditions, and with what runtime limits. That moves the issue into IAM and NHI governance because the agent is effectively a privileged non-human actor. Practitioners should treat agent identity, tool scope, and write-back authority as one control plane.

Destination-based security is insufficient for AI agents because the harmful action may happen inside the trust boundary. Allowlisted endpoints, internal vector stores, and approved workflow integrations all create the appearance of safety while hiding semantic abuse. This is the same pattern identity teams know from over-privileged service accounts: the channel looks legitimate while the behaviour is not. Practitioners should expect more AI-specific abuse of trusted paths, not fewer.

Write-path drift is the named concept healthcare teams should start governing explicitly. Write-path drift is the mismatch between an agent’s expected output behaviour and its observed runtime writes, recommendations, or workflow actions. In healthcare, that concept matters because harmful output can be operationally correct from a systems perspective and clinically wrong from a governance perspective. Teams should build detection and review around the output the agent is authorised to produce, not just the data it is authorised to access.

NHI controls now need to extend into AI-mediated clinical workflows. AI agents often inherit persistent permissions, delegated tool access, and implicit trust from the systems they automate. That makes least privilege, scoped delegation, and lifecycle governance relevant at the agent level, not just for human administrators or service accounts. Practitioners should review AI agents as governed identities with defined purpose, access scope, and revocation criteria.

Healthcare organisations should expect regulatory scrutiny to focus on traceability and accountability, not just model performance. If an AI agent can influence diagnosis, triage, or prior authorisation decisions, the governance question becomes whether the organisation can explain the chain from input to output. Frameworks such as the NIST AI Risk Management Framework and NIST Cybersecurity Framework are relevant because they push accountability, measurement, and response into the operating model. Practitioners should prepare for evidence-based control validation, not assumption-based assurance.

What this signals

AI-mediated healthcare security will increasingly depend on whether organisations can prove output integrity, not just access control. That is a meaningful shift for identity teams because agent identity, delegated tool access, and write-back authority are now part of the risk surface, especially where the workflow touches patient data or clinical recommendations.

Write-path drift: this is the control gap organisations will need to measure explicitly, because the dangerous event is often a normal-looking write inside an approved workflow. The practical response is to connect agent telemetry to identity governance, runtime baselines, and change management so that output anomalies do not get misclassified as routine model variation.

For practitioners building the next control layer, the most useful reference point is the NIST AI Risk Management Framework paired with identity governance discipline. If an AI agent can affect patient-facing outcomes, the programme needs evidence that access, behaviour, and revocation are all controlled together, not treated as separate teams' responsibilities.

For practitioners

• Implement per-agent runtime baselines Define normal read, write, tool-call, and output distributions for each clinical AI agent class, then alert on drift against that baseline rather than only on egress events.
• Separate write authority from read authority Review every AI agent that can access EHR or clinical knowledge stores and remove write-back permissions unless the workflow explicitly requires them and can be monitored.
• Correlate retrieval changes with downstream output Join retrieval corpus updates, prompt or context changes, and output shifts into one investigation path so that poisoned inputs are visible before they become clinical decisions.
• Treat AI agents as governed non-human identities Assign owners, lifecycle controls, and revocation triggers to each agent identity, especially where the agent can call tools or write into patient-facing systems.
• Validate clinical workflows against write-path drift Test whether the agent’s output remains within case-class expectations when the retrieval corpus, prompt template, or upstream content changes.

Key takeaways

• Healthcare AI detection fails when teams assume that authorised destinations are the same as safe outcomes.
• Agent output drift can be a security incident even when DLP, SIEM, CNAPP, and EHR audit logs remain quiet.
• The control that matters most is runtime governance of AI agent identity, permissions, and write-back behaviour.

Key terms

• Write-Path Drift: Write-path drift is the difference between an AI agent’s expected output behaviour and the writes it actually makes into a workflow, record, or knowledge store. It matters because a system can appear operationally healthy while producing clinically unsafe or manipulated results.
• Per-Agent Baseline: A runtime profile of normal tool use, destinations, and state changes for one specific agent deployment. It allows security teams to distinguish expected behaviour from coercion or drift, and it becomes the basis for moving from audit mode to enforced controls.
• Allowlisted Destination: An allowlisted destination is a system or service that security controls have already approved for traffic, data transfer, or workflow integration. In AI environments, an allowlisted destination can still be abused if the agent sends sensitive content or corrupted output through a trusted path.
• Cross-Correlation: Cross-correlation is the process of linking signals from multiple sources to build a stronger picture of identity behaviour. In practice, it combines logs, infrastructure artefacts, lifecycle records, and external data so that one weak signal becomes a coherent and actionable event.

What's in the full article

ARMO's full blog covers the operational detail this post intentionally leaves for the source:

• Per-agent runtime sensor design for healthcare workloads, including eBPF-based capture and workload overhead considerations.
• Application Profile DNA baseline methodology for different clinical agent classes and case types.
• CADR cross-layer correlation workflow showing how retrieval events, prompt context, and write-back actions are tied together.
• Example detection architecture for PHI exfiltration through allowlisted destinations and contaminated clinical output.

👉 ARMO's full post covers runtime baselines, CADR correlation, and clinical output drift detection examples.

Deepen your knowledge

The NHI Foundation Level course, the industry's only accredited NHI security programme, covers NHI governance, workload identity, secrets management, and identity lifecycle control. It gives practitioners a common control language for governing agents, service accounts, and other privileged non-human actors.